I propose to take Questions Nos. 572 and 573 together.
While pricing matters generally are a matter for my colleague the Minister for Finance, we continue to work together to ensure that public health impacts are central to considerations in relation to tobacco pricing.
In relation to the sale of cigarette packets containing more than 20 cigarettes, there is a lack of sufficient evidence that such packets impact on consumption or prevalence and therefore on public health. We will continue to monitor the emerging evidence and will take action if it becomes clear that it will have a public health benefit.